基于PI-RADS v2.1的多参数与双参数MRI及机器学习模型在前列腺癌诊断中的作用研究
研究纳入583例患者共594个病灶,比较基于PI-RADS v2.1的mpMRI与bpMRI诊断临床显著前列腺癌的效能,并利用PI-RADS评分和临床参数构建多种机器学习模型。mpMRI的AUC高于bpMRI(0.90 vs 0.88,p<0.05),mpMRI敏感度更高(93.1% vs 79.2%)但特异度更低(77.3% vs 86.2%)。机器学习模型诊断效能优异(AUC 0.91-0.96),mpMRI与bpMRI模型间无统计学显著差异。
要点
- mpMRI诊断csPCa的AUC为0.90,高于bpMRI的0.88(p<0.05)。
- mpMRI敏感度93.1%、特异度77.3%;bpMRI敏感度79.2%、特异度86.2%。
- 基于PI-RADS评分和临床参数的机器学习模型AUC达0.91-0.96。
核心结论
- 基于PI-RADS v2.1,mpMRI诊断csPCa的AUC高于bpMRI;利用PI-RADS评分和临床参数的机器学习模型诊断效能优异,且mpMRI与bpMRI模型间具有可比性。
研究设计与样本
- 纳入583例患者共594个病灶,均在接受MRI-经直肠超声融合靶向穿刺和系统穿刺前完成mpMRI;以穿刺病理为参考标准,比较bpMRI与mpMRI诊断csPCa的AUC,并构建机器学习模型;训练集475个病灶,测试集119个病灶。
诊断标准与关键数值
- 全部病灶中,bpMRI诊断csPCa的AUC为0.88,mpMRI为0.90(p<0.05);mpMRI敏感度93.1%、特异度77.3%,bpMRI敏感度79.2%、特异度86.2%;机器学习模型输入参数为bpMRI或mpMRI的PI-RADS评分、年龄、前列腺特异性抗原(PSA)、MRI定义的前列腺特异性抗原密度(PSAD)和前列腺体积(PV),mpMRI模型AUC 0.93-0.96,bpMRI模型AUC 0.91-0.94。
临床应用与阅片要点
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: We compared the diagnostic performance of multiparametric MRI (mpMRI) and biparametric MRI (bpMRI) in detecting clinically significant prostate cancer (csPCa) using the Prostate Imaging Reporting and Data System (PI-RADS) version 2.1. Additionally, we constructed multiple machine learning (ML) models for detecting csPCa using PI-RADS scores and clinical parameters.
MATERIALS AND METHODS: We enrolled 583 patients with 594 lesions who underwent mpMRI before MRI/transrectal ultrasound (MRI-TRUS) fusion-targeted biopsy and systematic biopsy. The diagnostic performance of bpMRI and mpMRI was analyzed by the area under the curve (AUC). We built multiple ML models for detecting csPCa. The input parameters were: PI-RADS scores in bpMRI or mpMRI, age, prostate-specific antigen (PSA), MRI-defined PSA density (PSAD), and prostate volume (PV). Training and test cohorts included 475 and 119 lesions, respectively.
RESULTS: The AUCs of bpMRI and mpMRI for the diagnosis of csPCa in total lesions were 0.88 and 0.90, respectively (p<0.05). mpMRI had higher sensitivity (93.1%) but lower specificity (77.3%) compared to bpMRI (sensitivity: 79.2%; specificity: 86.2%). All the ML models exhibited the high AUC in detecting csPCa (0.93-0.96 based on mpMRI models and 0.91-0.94 based on bpMRI models). There were no statistically significant differences in the AUC values between the two groups of ML models in test sets.
CONCLUSIONS: Compared to bpMRI, the AUC of mpMRI based on PI-RADS v2.1 to detect csPCa was higher. The diagnostic performance of ML models for detecting csPCa using PI-RADS scores and clinical parameters was excellent and comparable between mpMRI and bpMRI.
引用
- Zhuang D, Zhong S, Chen S, et al. Investigating the role of multiparametric and biparametric MRI based on PI-RADS v2.1 and machine learning models in prostate cancer diagnosis. Clin Radiol. 2025. PMID: 41016076. doi:10.1016/j.crad.2025.107070
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。